Header Logo

Connection

NAGIREDDY PUTLURI to Biomarkers, Tumor

Back to Details
This is a "connection" page, showing publications NAGIREDDY PUTLURI has written about Biomarkers, Tumor.
NAGIREDDY PUTLURI
Connection Strength
1.642
Biomarkers, Tumor
  1. A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women. Cancer Prev Res (Phila). 2019 04; 12(4):237-246.
    View in: PubMed
    Score: 0.354
  2. Pathway-centric integrative analysis identifies RRM2 as a prognostic marker in breast cancer associated with poor survival and tamoxifen resistance. Neoplasia. 2014 May; 16(5):390-402.
    View in: PubMed
    Score: 0.254
  3. Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression. Cancer Res. 2011 Dec 15; 71(24):7376-86.
    View in: PubMed
    Score: 0.213
  4. Transcriptional Repression of SIRT3 Potentiates Mitochondrial Aconitase Activation to Drive Aggressive Prostate Cancer to the Bone. Cancer Res. 2021 01 01; 81(1):50-63.
    View in: PubMed
    Score: 0.100
  5. Cerebrospinal fluid ctDNA and metabolites are informative biomarkers for the evaluation of CNS germ cell tumors. Sci Rep. 2020 08 31; 10(1):14326.
    View in: PubMed
    Score: 0.099
  6. Glioma induced alterations in fecal short-chain fatty acids and neurotransmitters. CNS Oncol. 2020 06; 9(2):CNS57.
    View in: PubMed
    Score: 0.097
  7. Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer. Clin Cancer Res. 2019 06 15; 25(12):3689-3701.
    View in: PubMed
    Score: 0.089
  8. Recent advances in the metabolomic study of bladder cancer. Expert Rev Proteomics. 2019 04; 16(4):315-324.
    View in: PubMed
    Score: 0.089
  9. Analysis of cerebrospinal fluid metabolites in patients with primary or metastatic central nervous system tumors. Acta Neuropathol Commun. 2018 08 31; 6(1):85.
    View in: PubMed
    Score: 0.086
  10. Tobacco-Specific Carcinogens Induce Hypermethylation, DNA Adducts, and DNA Damage in Bladder Cancer. Cancer Prev Res (Phila). 2017 Oct; 10(10):588-597.
    View in: PubMed
    Score: 0.080
  11. Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival. J Urol. 2016 06; 195(6):1911-9.
    View in: PubMed
    Score: 0.072
  12. Metabolic landscape in bladder cancer. Curr Opin Oncol. 2025 May 01; 37(3):259-266.
    View in: PubMed
    Score: 0.034
  13. The genomic alterations in glioblastoma influence the levels of CSF metabolites. Acta Neuropathol Commun. 2024 Jan 19; 12(1):13.
    View in: PubMed
    Score: 0.031
  14. KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer. Cancer Cell. 2020 04 13; 37(4):599-617.e7.
    View in: PubMed
    Score: 0.024
  15. Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases. Cancer Discov. 2019 05; 9(5):628-645.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.